Fondazione Telethon
Sede di Roma
Via Varese 16b
00185 | Roma

Sede di Milano
Via Poerio 14
20129 | Milano

Fondazione Telethon

Research Institutes

We are a non-profit organisation recognised by the Italian Ministry of Education, Universities and Research. We were founded in 1990 in response to calls by people suffering from rare diseases.

Right from the start, we have always listened to patients, to provide the answers they need. Every day.

We manage fund raising activities and guarantee the necessary resources for our research projects. These projects are subjected to rigorous assessments on the part of an independent, international Scientific and Medical Committee.

Research funds are assigned throught the help of:

  • Scientific and Medical Committee: follows the peer-review procedure. Before the plenary discussion, each proposed project is examined by three committee members and at least two external reviewers selected from the international community. Thanks to this process, we can be sure that only the best projects are chosen.
  • Scientific Steering Committee: the task of the Scientific Steering Committee is to support the overall policy and management decisions of the Board of Directors within the framework of biomedical research. Its members are Joel Gottesfeld, Michael Caplan, Lana Skirboll, Sharon Terry, Gregory Germino, Lynn Jorde, Petra Kaufmann, Samantha Truex.
We were made to give people affected by a rare genetic condition an answer - treatment for their condition.Often neglected by large public or industrial investment schemes, and the poor relation when it comes to research and drug treatments - rare genetic conditions are not statistically relevant when considered individually, but the same can't be said about a person's life.

What is our response to this silent emergency? The journey of scientific research towards a cure is lengthy, demanding, and punctuated by obstacles and successes, involving small steps towards enormous goals.

We work to transform the results of excellent, supported scientific research into drugs and treatments available to patients all over the world. 

For some years now this vision has been a reality, thanks to innovative treatments that attract the attention of increasing numbers of pharmaceutical groups, and partnerships with public and private health facilities, so our work doesn't just stop at successful scientific results, but actually becomes a reality for each and every patient.

We pursue our vision in two ways:
  • by continually supporting our Milan and Pozzuoli institutes, which are centres of excellence attracting researchers from all over the world.
  • by funding the best research in Italy, selecting the most promising projects using transparent methods that reward merit and excellence.